Reuters - Swiss pharmaceutical giant Novartis on Monday reported a 4 percent rise in net income to $1.713 billion, missing expectations as heavy charges from its acquisition of U.S. biotech firm Chiron weighed.

Reuters - Chiron Corp. on Monday said it reached an agreement under which Swiss drugmaker Novartis will raise its purchase offer to $48 per share for the portion of the U.S. biotechnology company it does not already own.

Reuters - Chiron Corp. on Friday said two proxy advisory services have reached opposite recommendations on whether the U.S. biotechnology company should be acquired by Swiss drugmaker Novartis AG.

Yvonne Lee - AHN Staff Reporter (AHN) - Chiron Corp. is recalling and withdrawing nearly 5.5 million doses of a measles, mumps and rubella vaccine available in developing countries and Italy. The California-based biotechnology company issued the recall as a precaution after reports of a higher...

AFP - US biotech company Chiron said it was recalling its measles, mumps and rubella (MMR) vaccine Morupar, of which it supplied five million doses last year, mainly to developing countries and some 450,000 doses to Italy.